This company has been marked as potentially delisted and may not be actively trading. NYSE:CRY CryoLife (CRY) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About CryoLife Stock (NYSE:CRY) 30 days 90 days 365 days Advanced Chart Get CryoLife alerts:Sign Up Key Stats Today's Range N/A50-Day Range$17.19▼$21.7252-Week Range N/AVolume7,792 shsAverage Volume198,221 shsMarket Capitalization$703.22 millionP/E Ratio596.20Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA. Read More CryoLife Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks27th Percentile Overall ScoreCRY MarketRank™: CryoLife scored higher than 27% of companies evaluated by MarketBeat, and ranked 796th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for CryoLife. Earnings and Valuation1.9 / 5Proj. Earnings Growth600.00% Earnings GrowthEarnings for CryoLife are expected to grow by 600.00% in the coming year, from $0.03 to $0.21 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CryoLife is 596.20, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.65.Price to Earnings Ratio vs. SectorThe P/E ratio of CryoLife is 596.20, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.65. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for CRY. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCryoLife does not currently pay a dividend.Dividend GrowthCryoLife does not have a long track record of dividend growth. Sustainability and ESG3.7 / 5Environmental Score-1.53 Short InterestThere is no current short interest data available for CRY. News and Social Media0.6 / 5News SentimentN/A Search Interest1 people have searched for CRY on MarketBeat in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, CryoLife insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.50% of the stock of CryoLife is held by insiders.Percentage Held by Institutions81.57% of the stock of CryoLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CryoLife's insider trading history. Receive CRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CryoLife and its competitors with MarketBeat's FREE daily newsletter. Email Address CRY Stock News Headlines1 Profitable Stock to Target This Week and 2 to Steer Clear OfApril 24, 2025 | msn.comCryoLife Stock Soars to 52-Week High, Hits $30.62January 16, 2025 | msn.comI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.July 6 at 2:00 AM | Porter & Company (Ad)US medical device giant Artivion says hackers stole files during cybersecurity incidentDecember 10, 2024 | finance.yahoo.comJudith Jamison, acclaimed Alvin Ailey American dancer and director, dead at 81November 11, 2024 | usatoday.comArtivion price target raised to $35 from $32 at Lake StreetNovember 10, 2024 | markets.businessinsider.comJudith Jamison, Alvin Ailey Dancer of ‘Power and Radiance,’ Dies at 81November 10, 2024 | nytimes.comArtivion (AORT) Receives a Buy from Lake StreetNovember 5, 2024 | markets.businessinsider.comSee More Headlines CRY Stock Analysis - Frequently Asked Questions How were CryoLife's earnings last quarter? CryoLife, Inc. (NYSE:CRY) posted its quarterly earnings data on Thursday, November, 4th. The medical equipment provider reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.22. The medical equipment provider had revenue of $72.21 million for the quarter, compared to analysts' expectations of $72.90 million. CryoLife had a trailing twelve-month return on equity of 4.24% and a net margin of 0.63%. Does CryoLife have any subsidiaries? CryoLife subsidiaries include these companies: JOTEC AG, On-X Life Technologies Inc., Hemosphere, Cardiogenesis Corporation, AuraZyme Pharmaceuticals Inc., CryoLife Asia Pacific PTE. Ltd., CryoLife Canada Inc., and more. What other stocks do shareholders of CryoLife own? Based on aggregate information from My MarketBeat watchlists, some other companies that CryoLife investors own include Energy Transfer (ET), Johnson & Johnson (JNJ), AT&T (T), Meta Platforms (META), Gilead Sciences (GILD), International Business Machines (IBM) and Netflix (NFLX). Company Calendar Last Earnings11/04/2021Today7/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & Medical Instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:CRY CIK784199 Webwww.cryolife.com Phone(770) 419-3355Fax770-426-0031Employees1,200Year Founded1984Profitability EPS (Trailing Twelve Months)$0.03 Trailing P/E Ratio596.20 Forward P/E RatioN/A P/E GrowthN/ANet Income-$16.68 million Net Margins0.63% Pretax Margin0.41% Return on Equity4.24% Return on Assets1.63% Debt Debt-to-Equity Ratio0.99 Current Ratio4.21 Quick Ratio2.93 Sales & Book Value Annual Sales$253.23 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow23.30 Book Value$8.46 per share Price / BookN/AMiscellaneous Outstanding Shares39,330,000Free Float37,560,000Market Cap$703.22 million OptionableOptionable Beta1.53 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free Report This page (NYSE:CRY) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredFINAL HOURS: $9 Income ETF Access VANISHES at MIDNIGHTTHIS IS IT. Your FINAL CHANCE. At midnight, our 82% OFF July 4th deal disappears FOREVER. The countdown ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CryoLife, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CryoLife With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.